ZYBERNO
Stock Report
Updated Aug 31, 2026

RAFAEL HOLDINGS, INC. (RFL)

Healthcare • NYSE

$2.46

Professional Investment Analysis

ZYBERNO SCORE
Is it a great business? Is it getting better?
30.0/100
WEAK BUSINESS
RAFAEL HOLDINGS, INC. (RFL) scores 30/100 — weak fundamentals with mixed indicators requiring careful analysis before acting.
📊 How is the Zyberno Score calculated? +
VALUATION SIGNAL
N/A (Requires more data)
Requires fair value calculation and current price data
💰 How is Margin of Safety calculated? +
📈 How is Brina Gap calculated? +

Critical Financial Health Indicators

Return on Equity (Profitability):CRITICAL (-23.6%)
Debt-to-Equity (Solvency Risk):EXCELLENT (0.00x)
Operating Margin (Operational Efficiency):CRITICAL (-3,717.2%)
Return on Capital (Capital Efficiency):CRITICAL (-54.1%)
📊 Valuation Trilogy
Three interconnected metrics for complete valuation analysis
Click any metric for full methodology and detailed analysis
Zyberno's Verdict

RAFAEL HOLDINGS, INC. (RFL) stock report — Zyberno Score 30/100 (WEAK BUSINESS). Full financial analysis on Zyberno.

Over the trailing twelve months, RFL generated -$18.93M in Owner Earnings. Capital was deployed as follows: $4.00K invested in capital expenditures. Reinvestment rate: -8.9%.

DIVISION I: EXECUTIVE SUMMARY
A. Market Valuation

Market Price & Capitalization (2)

Current Price:2.46
Market Cap:$133.79M

Valuation Multiples (3)

P/B Ratio:1.66x
P/S Ratio:136.52x
Peg Ratio:-999.00x

Enterprise Metrics (1)

Enterprise Value:$103.51M

Price Action & Momentum (3)

Momentum Percentile:90 / 100
% of 52-Week High:62.1%
B. Profitability Assessment

Return Metrics (5)

ROA:-20.2%
Reinvestment Rate:-8.9%
Fundamental Growth Rate (g):4.8%

Margin Analysis (3)

Operating Margin Ttm:-3,717.2%
Net Margin Ttm:-2,117.2%
Ebitda Margin:-3,696.5%

TTM Performance (2)

Operating Margin Ttm:-3,717.2%
Net Margin Ttm:-2,117.2%

Yield Metrics (2)

Earnings Yield:-$35.03
Dividend Yield:0.0%
C. Log-Linear Regression Growth Trends

Earnings Surprise (SUE) (3)

EPS Surprise vs Expected:-204.9%
Latest Earnings Filed:2026-06-11

Revenue Growth (Linear) (1)

Revenue Growth Rate (Linear):53.7%
D. Financial Stability

Liquidity Ratios (3)

Current Ratio:3.16x
Quick Ratio:3.14x
Cash Ratio:2.77x

Leverage Analysis (3)

Debt To Equity Ttm:0.00x
Debt-to-Equity Ratio:0.00x
Debt To Ebitda:-999.00x

Coverage Ratios (2)

Interest Coverage Ratio:-58.91x
Times Interest Earned:-58.91

Capital Structure (4)

Working Capital:23,838,000.00
Cash And Cash Equivalents:30,497,000.00
Long Term Debt:$27.00K
Net Debt:-$30.28M
DIVISION II: FINANCIAL STATEMENTS ANALYSIS
A. Income Statement Analysis

Revenue Components (2)

Revenue TTM: $980.00K
Linear Growth: 53.7%
📊 Click to view full RFL Revenue analysis & methodology →
Cost Of Revenue Ttm:$154.00K

Profitability Breakdown (2)

Gross profit TTM: $763.00K
Linear Growth: 66.0%
📊 Click to view full RFL Gross Profit analysis & methodology →
-$36.43M

Bottom Line Performance (3)

-$20.75M
Income Before Tax:-$31.19M
Ebitda Ttm:-36,226,000.00

Operating Expenses (5)

Operating Expenses:0.00
R And D Expense:17,098,000.00
Sga Expense:7,306,000.00
Income Tax Expense:-$110.00K
Interest Expense:495,000.00

Expense Ratios (3)

R And D To Revenue Percentage:9,552.0%
Sga To Revenue Percentage:4,081.6%
Ebitda Margin:-3,696.5%
B. Balance Sheet Analysis

Asset Composition (5)

Total Assets:$91.99M
Current Assets:$34.86M
Ppe Net:1,524,000.00
Goodwill:19,939,000.00
Intangible Assets:$896.00K

Liability Structure (4)

Total Liabilities:11,187,000.00
Current Liabilities:11,020,000.00
Long Term Debt:$27.00K
Short Term Debt:$188.00K

Equity & Capital (3)

Equity:$80.80M
Retained Earnings:-$252.72M
Common Stock:9,400,000.00

Working Capital Items (3)

Accounts Receivable:294,000.00
Inventory:276,000.00
Accounts Payable:7,043,000.00

Special Items (2)

Contract Liabilities:0.00
Stock Based Compensation:172,000.00
C. Cash Flow Analysis

Operating Activities (2)

-$22.69M-$22.69M

Investment Activities (2)

Investing Cash Flow:-$430.00K
Capital Expenditures Ttm:4,000.00

Financing Activities (3)

Financing Cash Flow:-$30.00K
Dividends Paid Ttm:0.00
Stock Repurchase:0.00

Capital Transactions (3)

Common Stock Issuance:99,170,000.00
Long Term Debt Issuance:$0.00
Long Term Debt Repayments:$0.00

Non-Cash Items (1)

Depreciation Amortization Ttm:203,000.00
DIVISION III: OPERATIONAL METRICS
A. Per Share Analysis

Earnings Per Share (3)

EPS (Basic TTM):-0.69
-$0.69
Earnings Per Share Ttm:-$0.38

Revenue & Cash Per Share (2)

Sales Per Share Ttm:0.02
Operating Cash Flow Per Share:-$0.35

Book Value & Capital (2)

Book Value Per Share:$1.49
Cash Per Share:0.56

Dividend Policy (1)

Dividend Payout Ratio:-999.00x
B. Operational Efficiency

Asset Utilization (2)

Asset Turnover Ttm:0.01x
Working Capital Turnover Ttm:0.04x

Receivables Management (2)

Receivables Turnover Ttm:3.33x
Days Sales Outstanding Ttm:109.50

Inventory Management (2)

Inventory Turnover Ttm:0.56x
Days Inventory Outstanding Ttm:654.16

Payables & Cash Cycle (2)

Days Payable Outstanding:16,692.82
Cash Conversion Cycle:-15,929.17
C. Quality & Risk Metrics

Financial Quality Scores (2)

Financial Strength Score:100.00
Quality Score:40.00

Market Metrics (2)

Beta:0.00x
Volatility Category:unknown
DIVISION IV: INVESTMENT ANALYSIS
A. Value Investment Framework

Owner Earnings Analysis (1)

-$18.93M

Damodaran Growth Analysis (2)

Reinvestment Rate:-8.9%
Fundamental Growth Rate (g):4.8%
B. Log-Linear Regression Growth Analysis

Growth Rates (Log-Linear Regression) (1)

Revenue Growth Rate (Linear):53.7%

Other Growth Rates (2)

Gross Profit Growth Rate (Linear):0.7%
Book Value Growth Rate (Linear):-4.6%
C. Company Profile & Context

Corporate Information (6)

Symbol:RFL
Company Name:RAFAEL HOLDINGS, INC.
Sector:Healthcare
Industry:Pharmaceuticals
Exchange:NYSE
Country:United States

Market Classification (3)

Market Cap Category:N/A
Price Category:low
Volume Category:N/A

Share Structure (3)

Shares Outstanding:54.39M
Shares Outstanding Basic:51.23M
Shares Outstanding Diluted:51.23M

Data Processing Info (3)

Processing Version:v3.0
Last Updated:2026-08-31 17:55:17 UTC
Data Timestamp:2026-08-19T16:44:54.503389
Scroll to Top